PainTrain-AI Implementation Trial in Primary Care (Competency Gaps and Gender Bias)
Not yet recruitingNot applicableNCT07507019
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Cluster trial to assess the effect of a digital clinical simulation (PainTrain AI) on clinical adequacy (0-100 rubric) across T0-T1-T2 in Primary Care. Secondary endpoints: SUS, adherence, low value practice indicators, and latency/friction. The intervention is educational/behavioral; the platform is non diagnostic and RAG fenced to validated content. Analysis per protocol: DiD and LMM/GLMM.
Study details
- Official title
- Implementation of the Digital Intervention PainTrain-AI in Primary Care: Competency Gaps and Gender Bias in the Management of Chronic Musculoskeletal Pain
- Conditions
- Educational Intervention for Primary Care Professionals on Chronic Musculoskeletal Pain
- Interventions
- Behavioral: PainTrain-AI Educational Training
- Behavioral: Usual Training / Standard Practice
- Sponsor
- Francesc Valenzuela Pascual
- Organization
- Universitat de Lleida
- Start date
- 2029-03
- Primary completion
- 2030-03
- Sex
- All
- Age range
- from 18 Years
- Healthy volunteers
- true
- Results posted
- No results posted in this snapshot
- Countries
- Spain
- Total sites listed
- 2
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Health professionals (medicine, nursing, physiotherapy, psychology, nutrition) working at participating Primary Care centers. * Active clinical practice during the study period. * Ability to access and use the digital platform (PainTrain-AI) and complete online assessments (T0, T1, T2). * Provides informed consent. Exclusion Criteria: * Prior exposure to the PainTrain-AI platform within the previous 12 months (risk of contamination). * Planned absence or temporary leave during the evaluation windows (T0, T1, T2). * Inability to use the digital platform for technical reasons not solvable by support. * Declines participation.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT07507019